Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Intensity Loading Dose Versus Standard Weekly Dosing of Ergocalciferol in Aggressive Non-Hodgkin Lymphoma
NCT07366450Not yet recruiting
- Sponsor
- Phramongkutklao College of Medicine and Hospital
- Start
- Feb 2026
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Phramongkutklao College of Medicine and Hospital. Primary endpoint: Proportion of Participants Achieving Vitamin D Normalization at Day 21. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT07366450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07366450.